Fidelity Investments’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $775K | Buy |
52,980
+4,859
| +10% | +$72K | ﹤0.01% | 3105 |
|
|
2026
Q1 | $698K | Buy |
48,121
+14,913
| +45% | +$173K | ﹤0.01% | 2993 |
|
|
2025
Q4 | $319K | Buy |
33,208
+12,461
| +60% | +$119K | ﹤0.01% | 3247 |
|
|
2025
Q3 | $195K | Sell |
20,747
-8,328
| -29% | -$79.5K | ﹤0.01% | 3354 |
|
|
2025
Q2 | $308K | Buy |
29,075
+2,829
| +11% | +$35.7K | ﹤0.01% | 3155 |
|
|
2025
Q1 | $394K | Sell |
26,246
-710
| -3% | -$11.8K | ﹤0.01% | 2983 |
|
|
2024
Q4 | $444K | Buy |
26,956
+2,235
| +9% | +$44.1K | ﹤0.01% | 2976 |
|
|
2024
Q3 | $611K | Buy |
24,721
+4,996
| +25% | +$130K | ﹤0.01% | 2770 |
|
|
2024
Q2 | $500K | Buy |
19,725
+5,075
| +35% | +$132K | ﹤0.01% | 2731 |
|
|
2024
Q1 | $372K | Buy |
14,650
+3,165
| +28% | +$76.6K | ﹤0.01% | 2822 |
|
|
2023
Q4 | $260K | Sell |
11,485
-1,790
| -13% | -$37K | ﹤0.01% | 2875 |
|
|
2023
Q3 | $247K | Sell |
13,275
-3,230
| -20% | -$67K | ﹤0.01% | 2824 |
|
|
2023
Q2 | $429K | Buy |
16,505
+200
| +1% | +$5.35K | ﹤0.01% | 2705 |
|
|
2023
Q1 | $468K | Sell |
16,305
-68
| -0.4% | -$2.02K | ﹤0.01% | 2711 |
|
|
2022
Q4 | $485K | Sell |
16,373
-114
| -0.7% | -$3.24K | ﹤0.01% | 2730 |
|
|
2022
Q3 | $393K | Sell |
16,487
-883
| -5% | -$20.3K | ﹤0.01% | 2854 |
|
|
2022
Q2 | $388K | Buy |
17,370
+4,500
| +35% | +$100K | ﹤0.01% | 2924 |
|
|
2022
Q1 | $323K | Buy |
12,870
+12,794
| +16,834% | +$390K | ﹤0.01% | 3118 |
|
|
2021
Q4 | $3K | Sell |
76
-6
| -7% | -$240 | ﹤0.01% | 3898 |
|
|
2021
Q3 | $3K | Hold |
82
| – | – | ﹤0.01% | 3892 |
|
|
2021
Q2 | $4K | Sell |
82
-69
| -46% | -$2.94K | ﹤0.01% | 3751 |
|
|
2021
Q1 | $6K | Buy |
151
+75
| +99% | +$2.85K | ﹤0.01% | 3492 |
|
|
2020
Q4 | $3K | Hold |
76
| – | – | ﹤0.01% | 3506 |
|
|
2020
Q3 | $3K | Sell |
76
-3
| -4% | -$108 | ﹤0.01% | 3383 |
|
|
2020
Q2 | $3K | Sell |
79
-80
| -50% | -$2.64K | ﹤0.01% | 3299 |
|
|
2020
Q1 | $5K | Sell |
159
-215
| -57% | -$8.7K | ﹤0.01% | 3244 |
|
|
2019
Q4 | $19K | Buy |
374
+169
| +82% | +$9.82K | ﹤0.01% | 3118 |
|
|
2019
Q3 | $11K | Sell |
205
-48
| -19% | -$2.46K | ﹤0.01% | 3201 |
|
|
2019
Q2 | $10K | Buy |
253
+91
| +56% | +$3.32K | ﹤0.01% | 3227 |
|
|
2019
Q1 | $5K | Buy |
162
+21
| +15% | +$719 | ﹤0.01% | 3248 |
|
|
2018
Q4 | $5K | Sell |
141
-73
| -34% | -$2.63K | ﹤0.01% | 3172 |
|
|
2018
Q3 | $9K | Buy |
+214
| New | +$8.46K | ﹤0.01% | 3144 |
|
|
2017
Q1 | – | Sell |
-36,200
| Closed | -$1.77M | – | 2642 |
|
|
2016
Q4 | $1.77M | Buy |
+36,200
| New | +$1.67M | ﹤0.01% | 2394 |
|
Other funds holding ANIK
CP
BFM
CM
Fidelity Investments's ANIK Position: Q2 2026 in Review
Fidelity Investments increased its Anika Therapeutics (ANIK) stake by 10% in Q2 2026, buying an estimated $72K and bringing the position to 52,980 shares worth $775K. The position accounts for ﹤0.01% of the portfolio, ranked #3105.
Fidelity Investments first reported a position in ANIK in Q4 2016 and has held it in 33 quarters since. The position peaked at $1.77M in Q4 2016. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- Fidelity Investments held 52,980 shares of Anika Therapeutics worth $775K as of Q2 2026.
- Fidelity Investments bought 4,859 Anika Therapeutics shares in Q2 2026, an estimated $72K.
- Anika Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3105 holding.
- Fidelity Investments first reported a position in Anika Therapeutics in Q4 2016 and has held it in 33 quarters since.
- Fidelity Investments's Anika Therapeutics position peaked at $1.77M in Q4 2016.
- 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.